Compare KRMD & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | HBIO |
|---|---|---|
| Founded | 1980 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.6M | 33.8M |
| IPO Year | N/A | 2000 |
| Metric | KRMD | HBIO |
|---|---|---|
| Price | $5.61 | $0.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $5.88 | $2.50 |
| AVG Volume (30 Days) | 179.3K | ★ 576.2K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $39,070,637.00 | ★ $87,371,000.00 |
| Revenue This Year | $23.36 | N/A |
| Revenue Next Year | $18.63 | $7.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.12 | N/A |
| 52 Week Low | $1.86 | $0.28 |
| 52 Week High | $6.61 | $2.28 |
| Indicator | KRMD | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 43.49 |
| Support Level | $5.55 | $0.71 |
| Resistance Level | $6.61 | $0.80 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 14.13 | 4.75 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.